Enzyme-mediated immunoassay (EMIT) serum aminoglycoside assay results were accurate and precise and correlated well with radioimmunoassay, fluoroimmunoassay, and acetyltransferase and microbiological assay determinations.
compared EMIT with the microbiological assay, acetyltransferase assay, RIA, and fluoroimmunoassay.
All assays were done with five or six calibrators (0, 1, 2, 4, 8, and 16 ,ug/ml) prepared in pooled human serum, except for the quenching fluoroimmunoassay, for which the top calibrator was 12 ,ug/ml, and most EMIT assays, for which the 16-,ug/ml calibrator was excluded (see below). The microbiological assay was a large-plate method, with Klebsiella edwardsii subsp. atlantae (NCTC 10896) as the indicator organism (13) . The acetyltransferase assay was performed as described by Broughall and Reeves (3) .
[125I]gentamicin RIA kits (Diagnostic Products Corp., Los Angeles, Calif.), quenching fluoroimmunoassay kits (Technia Diagnostics Limited, London, England), and substrate-labeled fluoroimmunoassay kits (Ames Laboratories, Elkhart, Ind.) were used according to the manufacturers' instructions. EMIT-AMD kits (lot J03; Syva) were used. Manual assays were performed according to the manufacturers' instructions in a Gilford Stasar III linked to a CP5000 clinical processor (Syva). Samples and reagents were simultaneously diluted and dispensed into autoanalyzer cups (Syva) with a pipettor diluter (Syva model 1500). Standard curves were plotted manually on the graph paper supplied with the kits.
Preliminary studies with EMIT indicated that some autoanalyzer cups (from suppliers other than Syva) gave poor precision, as did any protocol which allowed insufficient time for the first dilutions of sample to equilibrate. All EMIT results reported here were obtained by using Syva cups and a protocol allowing first dilutions of at least 1-min equilibration. The 16-,ug/ml calibrator, both neat and diluted 1:6, and the 2- ,ug/ml calibrator were assayed 12 times (six duplicates). Coefficients of variation were 11.28, 5.4, and 3.5%, respectively. The results for the 2-,ug/ml and 16-yg/ml (assayed diluted) calibrators were accurate (2 + 0.07 and 15.7 + 0.85 ,g/ml).
In contrast, the mean result for the 16-,ug/ml standard, assayed undiluted, was only 12.4 ± 1.4 ,ug/ml. At between 10 and 16 ug/ml a large increase in aminoglycoside concentration produces only a small increase in enzyme activity;
we therefore decided to exclude the 16-,ug/ml calibrator. When a sample containing >8 ,ug/ml was encountered, it was immediately diluted to bring it within the range of 2 to 8 ,ug/ml and reassayed.
To check accuracy, six samples from the United Kingdom gentamicin assay quality control circulation and three gentamicin quality control samples from the United States were assayed. EMIT results showed a mean error of only -3.02% (standard deviation, 3.92).
Sera spiked with tobramycin, amikacin, streptomycin, spectinomycin, and netilmicin (1 to 40 ,ug/ml) were assayed to check EMIT specificity. Only netilmicin-containing sera cross-reacted and gave between 70 and 40% of the response of gentamicin.
Fifty-two clinical serum samples were assayed for gentamicin (when possible) by EMIT, microbiological assay, RIA, fluoroimmunoassay, and acetyltransferase assay: 40 of these were assayed by all methods. Correlation coefficients and regression curves are shown in Fig. 1 In a more limited study of the tobramycin assay kit, we found that there was no crossreaction with gentamicin, and with 10 clinical specimens containing tobramycin we obtained a correlation coefficient of 0.95 between EMIT and plate assay results and one of 0.99 between EMIT and substrate-labeled fluoroimmunoassay results.
Standard curves for gentamicin or tobramycin generated over a period of 20 days from single kits showed excellent reproducibility; the only value which changed significantly was the absorbance reading of the zero calibrator(i.e., the blank), which gradually increased over the period.
Aminoglycoside assay by EMIT proved to be rapid; to construct a standard curve and assay a pair of samples in duplicate took <15 min. This compared favorably with up to 18 h for microbiological assays (2) and 45 to 90 min for fluoroimmunoassay (13) more time for the samples to travel from patient to laboratory; thus, samples from other hospitals can be assayed and reported within minutes of receipt, and skilled personnel have more time to devote to other tasks.
EMIT, as performed in this study, is technically very simple, but our results indicate that a protocol allowing first dilutions to equilibrate before second dilutions are made should be used and the precision-performnance of autoanalyzer cups other than those recommended by Syva should be checked. With optimnal protocol and cups we obtained coefficients of variation of around 5%. The makers claim coefficients of variation of <10%. Because dilution and reassay are rapid by EMIT, we limited our top calibrator to 8 ,ug/ml and diluted and reassayed all samples of >8 ,Ag/ml. The extra precision thus obtained has less importance clinically than with lower values, but it is necessary when standard solutions are assayed or pharmacokinetic data are being obtained.
When British and American gentamicin quality control samples were assayed, EMIT discrepancies were always slight underestimates, but the significance of this is unclear since the mean results from other laboratories assaying these samples by other methods were similarly slight underestimates of the assigned values (unpublished data).
We found good correlation between the results of EMIT and those of microbiological assay, acetyltransferase assay, RIA, and fluoroimmunoassay. The mean acetyltransferase result was about 10% higher and the mean fluoroimmunoassay result was about 10% lower, but these discrepancies are probably of little significance for clinical assays. Sanders et al. (10) found a similar good correlation between EMIT and RIA but a poorer correlation between EMIT and a microbiological assay when a gram-positive indicator organism was used.
With the gentamicin assay reagents there was significant cross-reaction with netilmicin. Since netilmicin and gentamicin are almost never coprescribed, this should cause no problems in practice; in fact, netilmicin can be assayed with EMIT gentamicin reagents and netilmicin calibrators (unpublished data).
We conclude that, when technical simplicity, speed, versatility, and high specificity are required, EMIT seems to be an excellent choice for gentamicin or tobramycin assay.
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